Bogenschutz M

Department of Psychiatry, NYU Grossman School of Medicine; NYU Langone Center for Psychedelic Medicine, New York, NY, USA.

2 preprints · 6 papers · ORCID

PreprintPsilocybin

Safety and Efficacy of Psilocybin-Assisted Therapy for Alcohol Use Disorder: Open-Label Extension of a Phase II Randomized Controlled Trial

Pagni BA, Ross S, Mennenga S +11

PreprintPsilocybin

Psilocybin-Assisted Therapy Increases Self-Compassion in Patients with Alcohol Use Disorder

Agin-Liebes G, Petridis P, Zeifman R +3

ArticlePsilocybin

Self-reported experiences and perspectives on using psychedelics to manage opioid use among participants of two Reddit communities.

Krawczyk N, Miller M, Gu EY +7

Author Correction: MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.

Mitchell JM, Ot'alora G M, van der Kolk B +16

ArticlePsilocybin

300 Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: An fMRI pilot study

Pagni B, Petridis P, Podrebarac S +3

MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.

Mitchell JM, Ot'alora G M, van der Kolk B +16

MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.

Mitchell JM, Bogenschutz M, Lilienstein A +35

ArticlePsilocybin

Reports of self-compassion and affect regulation in psilocybin-assisted therapy for alcohol use disorder: An interpretive phenomenological analysis.

Agin-Liebes G, Nielson EM, Zingman M +5